Antengene Corporation Limited (HKG:6996)
Hong Kong · Delayed Price · Currency is HKD 3.460
+0.060 (1.76%)
Sep 30, 2026, 4:08 PM HKT
Antengene Corporation Market Cap
Antengene Corporation has a market cap or net worth of 2.38 billion as of October 1, 2026. Its market cap has decreased by -46.61% in one year.
Market Cap
2.38B
Enterprise Value
1.78B
Revenue
652.54M
Ranking
n/a
PE Ratio
35.64
Stock Price
3.46
ChartMarket Cap Chart
Since November 20, 2020, Antengene Corporation's market cap has decreased from 12.21B to 2.38B, a decrease of -80.53%. That is a compound annual growth rate of -24.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 2.38B | -7.60% |
| Dec 31, 2025 | 2.57B | 482.90% |
| Dec 31, 2024 | 441.64M | -67.28% |
| Dec 29, 2023 | 1.35B | -61.17% |
| Dec 30, 2022 | 3.48B | -46.78% |
| Dec 31, 2021 | 6.53B | -43.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioDlink International Company | 2.86B |
| Laekna | 2.71B |
| Jiangsu Recbio Technology | 2.71B |
| Beijing Luzhu Biotechnology | 2.69B |
| HJ Science | 2.66B |
| Clover Biopharmaceuticals | 2.48B |
| Frontage Holdings | 2.40B |
| AIM Vaccine | 2.12B |